University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Quadrupling Inhaled Gluococorticoid Dose To Abort Asthma Exacerbations

Simple item page
dc.contributor.authorMcKeever, Tricia
dc.contributor.authorMortimer, Kevin
dc.contributor.authorWilson, Andrew
dc.contributor.authorWalker, Samantha
dc.contributor.authorBrightling, Christopher
dc.contributor.authorSkeggs, Andrew
dc.contributor.authorPavord, Ian D.
dc.contributor.authorPrice, David B.
dc.contributor.authorDuley, Lelia
dc.contributor.authorThomas, Mike
dc.contributor.authorBradshaw, Lucy
dc.contributor.authorHiggins, Bernard
dc.contributor.authorHaydock, Rebecca
dc.contributor.authorMitchell, Eleanor J
dc.contributor.authorDevereux, Graham
dc.contributor.authorHarrison, Timothy
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Grampian Data Safe Haven (DaSH)en
dc.date.accessioned2018-09-03T23:02:36Z
dc.date.available2018-09-03T23:02:36Z
dc.date.embargoedUntil2018-09-03
dc.date.issued2018-03-08
dc.descriptionSupported by the Health Technology Assessment Programme of the National Institute for Health Research. We thank the trial participants, all the staff at the trial sites and the Nottingham Clinical Trial Unit who managed the trial, the members of the independent trial steering committee (Philip Ind [chair], consultant respiratory physician, Imperial College Healthcare NHS Trust; Adel Mansur, consultant physician, Birmingham Heartlands Hospital; Jacqui Cooper, chronic obstructive pulmonary disease–respiratory team leader, Keyworth Primary Care Centre; and Kim-Leng Hills, patient representative), and the members of the independent data monitoring committee (Steven Julious [chair], professor of medical statistics, University of Sheffield; Ian Sabroe, professor of inflammation biology, University of Sheffield; and Stephen Scott, consultant respiratory physician, Countess of Chester Hospital).en
dc.description.statusPeer revieweden
dc.format.extent9
dc.format.extent276741
dc.identifier115118509
dc.identifier0e610000-6e2d-4ce3-868d-8ef1081a0e13
dc.identifier85043573701
dc.identifier.citationMcKeever, T, Mortimer, K, Wilson, A, Walker, S, Brightling, C, Skeggs, A, Pavord, I D, Price, D B, Duley, L, Thomas, M, Bradshaw, L, Higgins, B, Haydock, R, Mitchell, E J, Devereux, G & Harrison, T 2018, 'Quadrupling Inhaled Gluococorticoid Dose To Abort Asthma Exacerbations', The New England Journal of Medicine, vol. 378, no. 10, pp. 902-910. https://doi.org/10.1056/NEJMoa1714257en
dc.identifier.doi10.1056/NEJMoa1714257
dc.identifier.iss10en
dc.identifier.issn0028-4793
dc.identifier.urihttp://hdl.handle.net/2164/11041
dc.identifier.vol378en
dc.language.isoeng
dc.relation.ispartofThe New England Journal of Medicineen
dc.subjectR Medicine (General)en
dc.subjectNational Institute for Health Research (NIHR)en
dc.subjectISRCTN15441965en
dc.subject.lccR1en
dc.titleQuadrupling Inhaled Gluococorticoid Dose To Abort Asthma Exacerbationsen
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
nejmoa1714257.pdf
Size:
270.25 KB
Format:
Adobe Portable Document Format
Download

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
8.29 KB
Format:
Plain Text
Description:
Download

Collections

All research
Applied Health Sciences research
University Office research